heapsreal
iherb 10% discount code OPA989,
- Messages
- 10,227
- Location
- australia (brisbane)
group hug!
But keep your hands where we can see them :tongue:
Why do you think this is odd? Thanks.Regarding the original Lomabardi paper I think it's odd that they didn't do some real time qPCR or reverse transcriptase PCR (at least I don't think they did) do they ever explain why?
But if they don't test blood/PBMCs for provirus how do they know if it's disappeared or not? Given that Lombardi used nested PCR to detect provirus DNA in blood samples, the negative XMRV studies used nested PCR to look for provirus DNA in blood samples but this study didn't use nested PCR to look for provirus DNA in blood samples I honestly don't see the relevance WRT the methodologies.
Another problem is that the main conclusion of this Switzer paper is that XMRV has no role in prostate cancer and this is most likely what explains the pattern of detection of provirus and viremia.
Regarding the original Lomabardi paper I think it's odd that they didn't do some real time qPCR or reverse transcriptase PCR (at least I don't think they did) do they ever explain why?
Why do you think this is odd? Thanks.
I can't see any results for RT-PCR in the addendum.
Mikovits has talked about some researchers' PCR tests being too specific, and that she has calibrated her techniques to be quite unspecific
The WPI has repeatedly stated that PCR testing at current levels of sensitivity, due to low viral counts in plasma, is relatively ineffective.
Most negative studies have elected to only use PCR, despite WPI's warnings, hence they have done nothing more than validate the ineffectiveness of PCR testing at present. They have not disproved evidence of XMRV. They have not progressed the science any further.
Furthermore they have failed to fully utilize the other more effective techniques used by WPI to detect XMRV. Why? Is it because they are not interested in validating XMRV so much as trying to win the race for a cheap commercial assay, or are they merely trying to sabotage the original findings for personal reasons? Either possibility is not such a noble one.
A simple search on this forum will reveal that many of those involved in negative studies have patents on XMRV strains, representing conflicts of interest (arguably fraudulent misrepresentation). Other groups who have wasted millions of dollars of research funding on dead end investigations also have much to lose in future funding. If anyone still doesn't understand the high stakes involved and that egos and greed are involved, then they need to do a lot more reading. XMRV, if proven to be the cause of me/cfs will destroy the careers of many, from researchers to bureaucrats to patient advocate organizations.
Contamination and recombination will ultimately be proven to be integral elements in the genesis and spread of XMRV and other variants, but not in the way the contamination cabal has tried to portray. Ironically there is a kernal of truth amidst the lies. Switzer's latest study and the report of rampant contamination and high rates of transmission of MLVs in exnografts is the beginning of the end for the contamination lobby, but should also send alarm bells ringing.
MLV recombinants were created in the lab and carelessly released into the public arena. Those responsible must be held to account. Those who are callously covering up this culpability must also be held to account, because every minute another life is lost, and the suffering of millions continues.
Furthermore, I don't believe we have begun to plumb the depths of MLV recombinations yet. While XMRV shows low propensity for mutation, MLVs appear to have high recombinant propensity, with individual strains displaying unique pathogenesis. Who knows what forms will eventually arise? Potentially it could be more devastating than HIV.